Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance

Minimal-change nephrotic syndrome (MCNS) is a common cause of steroid sensitive nephrotic syndrome (NS) with frequent relapse. Although steroids and calcineurin inhibitors (CNIs) are the cornerstone treatments, the use of rituximab (RTX), a monoclonal antibody targeting B cells, is an efficient and...

Full description

Saved in:

Bibliographic Details
Published in:	Nephrology, dialysis, transplantation Vol. 29; no. 11; p. 2084
Main Authors:	Guitard, Joëlle, Hebral, Anne-Laure, Fakhouri, Fadi, Joly, Dominique, Daugas, Eric, Rivalan, Joseph, Guigonis, Vincent, Ducret, Françis, Presne, Claire, Pirson, Yves, Hourmant, Maryvonne, Glachant, Jean-Claude, Vendrely, Benoit, Moranne, Olivier, Faguer, Stanislas, Chauveau, Dominique
Format:	Journal Article
Language:	English
Published:	England 01.11.2014
Subjects:	Adolescent Adult Aged Antibodies, Monoclonal, Murine-Derived - administration & dosage Antigens, CD20 B-Lymphocytes - drug effects B-Lymphocytes - immunology Biopsy Child Child, Preschool Drug Tolerance Female Glucocorticoids - pharmacology Humans Immunity, Cellular - drug effects Immunologic Factors - administration & dosage Infant Male Middle Aged Nephrosis, Lipoid - drug therapy Nephrosis, Lipoid - immunology Nephrosis, Lipoid - pathology Remission Induction Retrospective Studies Rituximab Time Factors Treatment Outcome B-cells steroids minimal-change disease nephrotic syndrome rituximab
ISSN:	1460-2385, 1460-2385
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!